---
title: Treatment-bacterial endocarditis
alias: Rx_IE
---

# Treatment-bacterial endocarditis

## Empiric

NVE or PVE >12 mos post-op: vanc + CTX
PVE <12 mos post op: vanc + CTX ± gentamicin (if OK renal fxn)

## Strep

Penicillin, ampicillin, cftx; if PVE consider gentamicin in discussion w/ ID

## Staph (S. aureus and lugdunensis)

MRSA: vanc or dapto
MSSA: nafcillin, oxacillin, or cefazolin (avoid if CNS involvement due to poor penetration);
**vanc inferior to β-lactam for MSSA**
For PCN allergy w/ MSSA consider desensitization
Consider rifampin / gentamicin in PVE in discussion w/ ID

## Enterococci

Ampicillin + [CTX or gent]; if VRE: linezolid, dapto, ampicillin if sensitive

## Gram negatives

HACEK: CTX, ampicillin or FQ. Pseudomonas: 2 anti-Pseudomonal agents [eg, β-lactam + (aminoglycoside or FQ)]

## Fungi (candida, aspergillus)

Candida: amphotericin B ± flucytosine or micafungin
Aspergillus: amphotericin B or voriconazole
Ophtho consult for fungemia to rule out endophthalmitis

- De-escalate abx to organism-directed therapy based on speciation and sensitivities
- If on anticoagulation or antiplatelet, **typically can continue** unless concern for stroke, intracranial hemorrhage, or need for emergent surgery
- Monitor for [[complications of endocarditis]]
- Duration is usually **4–6 wks**
  After ≥10d IV abx can consider ∆’ing to PO if clinically appropriate and available PO abx in consultation with ID (NEJM 2019;380:415)
  Uncomplicated right-sided NVE or PCN-S Strep spp → 2 wks may be adequate

- IVDU-associated best managed by multidisciplinary teams including Addiction Medicine
